Document Detail

Dialysis patients treated with Epoetin α show improved exercise tolerance and physical function: A new analysis of the Canadian Erythropoietin Study Group trial.
MedLine Citation:
PMID:  21138518     Owner:  NLM     Status:  Publisher    
The risks/benefits of anemia treatment in dialysis patients have been redefined in the US Epoetin α label. This analysis was carried out to determine if increasing hemoglobin (Hb) levels improve exercise tolerance and physical function in anemic dialysis patients. This is a new analysis of the Canadian Erythropoietin Study Group trial, a double-blind, randomized, placebo-controlled trial in dialysis patients. Subjects were 18 to 75 years old, on hemodialysis for >3 months, and had a baseline Hb <9.0 g/dL. Patients with a history of diabetes mellitus, ischemic heart disease, or severe/uncontrolled hypertension were excluded. Patients were randomized to receive Epoetin α to a target Hb of 9.5 to 11.0 g/dL (n=40) or a target of 11.5 to 13.0 g/dL (n=38), or receive placebo (n=40). Results from patients in the Epoetin-α-treated arms were combined for this analysis. Hb level, exercise tolerance (Treadmill Stress Test and 6-Minute Walk Test) and patient-reported physical function measures (Physical Summary domain from the Kidney Disease Questionnaire, and 4 domains from the Sickness Impact Profile) were reported at baseline and months 2, 4, and 6. Differences in measures were statistically significant for exercise tolerance (Treadmill Stress, P=0.0001) and patient-reported physical function (Kidney Disease Questionnaire Physical, P=0.0001; Sickness Impact Profile Physical, P=0.0015) across all time points for Epoetin-α-treated patients compared with placebo. Improvements were seen at 2 months and were maintained through months 4 and 6. Dialysis patients receiving Epoetin α showed improved exercise tolerance and physical function. These findings should be considered as physicians weigh the risks and benefits of treatment.
Norman Muirhead; Paul A Keown; David N Churchill; Melanie Poulin-Costello; Sandeep Gantotti; Lei Lei; Matthew Gitlin; Tracy J Mayne
Related Documents :
11713908 - Electroglottographic and acoustic changes following type i thyroplasty or autologous fa...
10268 - Observations on immobilization of père david's deer.
7404188 - Hypokalaemic myopathy.
6801738 - Seasonal variation in thyrotropin-releasing hormone (trh) content of different brain re...
6252748 - Effect of physical training on skeletal muscle metabolism and ultrastructure in 70 to 7...
8928898 - Involvement of transcription factor c/ebp-beta in stimulation of pepck gene expression ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2010-12-7
Journal Detail:
Title:  Hemodialysis international. International Symposium on Home Hemodialysis     Volume:  -     ISSN:  1542-4758     ISO Abbreviation:  -     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-12-8     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101093910     Medline TA:  Hemodial Int     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2010 The Authors. Hemodialysis International © 2010 International Society for Hemodialysis.
London Health Sciences Centre, University Hospital, University of Western Ontario, London, Ontario, Canada Departments of Medicine and Immunology, Division of Nephrology, University of British Columbia, Vancouver, British Columbia, Canada Amgen Canada Inc., Mississauga, Ontario, Canada Amgen Canada Inc., Mississauga, Ontario, Canada Amgen Inc., Thousand Oaks, California, USA DaVita Inc., El Segundo, California, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Comparison of QT peak and QT end interval responses to autonomic adaptation in asymptomatic LQT1 mut...
Next Document:  Phosphate-binding efficacy of crushed vs. chewed lanthanum carbonate in hemodialysis patients.